#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13248	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2184	603.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1695	1695	T	734	T,C	666,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13248	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2184	603.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1429	1429	C	795	C,G	743,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25232	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3650	689.0	0	.	n	.	0	C543T	SNP	543	543	C	943	943	T	820	T,C	774,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25232	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3650	689.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1737	1737	A	808	A	755	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25232	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3650	689.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2371	2371	C	767	C	718	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25232	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3650	689.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2445	2445	A	861	A	811	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25232	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3650	689.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2997	2997	C	728	C	689	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1794	folP	855	855	99.88	folP.l15.c4.ctg.1	1580	113.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1022	1024	AGC	166;164;167	A;G;C	154;153;154	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4180	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3199	129.5	0	.	p	.	0	V290I	NONSYN	868	870	GTT	1031	1033	ATT	107;107;107	A;T;T	105;104;105	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4180	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3199	129.5	1	SNP	p	S91F	0	.	.	271	273	TCC	434	436	TCC	141;143;145	T;C;C	130;133;134	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4180	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3199	129.5	1	SNP	p	D95G	0	.	.	283	285	GAC	446	448	GAC	148;148;146	G;A;C	137;135;136	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4180	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3199	129.5	1	SNP	p	D95N	0	.	.	283	285	GAC	446	448	GAC	148;148;146	G;A;C	137;135;136	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1414	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1307	107.1	1	SNP	p	G45D	1	.	.	133	135	GAC	547	549	GAC	162;163;160	G;A;C	152;153;150	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	786	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	884	87.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4242	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2757	152.5	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1526	1528	GCA	169;170;169	G;C,T;A,G	157;156,1;152,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4242	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2757	152.5	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2009	2011	ATT	184;182;180	A;T;T	173;171;169	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4242	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2757	152.5	1	SNP	p	D86N	0	.	.	256	258	GAC	479	481	GAC	167;169;171	G;A;C	156;154;161	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4242	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2757	152.5	1	SNP	p	S87W	0	.	.	259	261	AGT	482	484	AGT	174;176;179	A;G;T	163;165;166	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4242	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2757	152.5	1	SNP	p	S87I	0	.	.	259	261	AGT	482	484	AGT	174;176;179	A;G;T	163;165;166	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4242	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2757	152.5	1	SNP	p	S87R	0	.	.	259	261	AGT	482	484	AGT	174;176;179	A;G;T	163;165;166	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4242	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2757	152.5	1	SNP	p	S88P	0	.	.	262	264	TCC	485	487	TCC	179;177;175	T;C;C,A	165;167;164,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3624	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2645	136.4	0	.	p	.	0	H611N	NONSYN	1831	1833	CAC	2152	2154	AAC	144;143;142	A,C;A;C	132,2;131;135	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3624	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2645	136.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1549	1551	GGC	161;160;159	G;G;C	145;144;142	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	0	.	p	.	0	A438V	NONSYN	1312	1314	GCA	1599	1601	GTC	198;199;196	G;T;C	183;184;180	.	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	0	.	p	.	0	V444E	NONSYN	1330	1332	GTT	1617	1619	GAA	191;193;193	G;A;A	177;181;178	.	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	0	.	p	.	0	L448V	NONSYN	1342	1344	CTC	1629	1631	GTC	194;195;191	G;T;C	182;181;179	.	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	0	.	p	.	0	Q458K	NONSYN	1372	1374	CAA	1659	1661	AAA	173;169;168	A;A;A	162;159;157	.	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	0	.	p	.	0	I462V	NONSYN	1384	1386	ATA	1671	1673	GTC	175;176;175	G;T;C	158;158;159	.	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	0	.	p	.	0	F463I	NONSYN	1387	1389	TTC	1674	1676	ATC	174;173;174	A;T;C	160;158;159	.	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	0	.	p	.	0	E465A	NONSYN	1393	1395	GAA	1680	1682	GCC	172;172;173	G;C,T;C	157;156,1;156	.	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	0	.	p	.	0	R469K	NONSYN	1405	1407	CGC	1692	1694	AAA	167;168;170	A;A;A	155;155;157	.	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	0	.	p	.	0	E470K	NONSYN	1408	1410	GAG	1695	1697	AAA	169;169;165	A;A;A	155;155;149	.	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	0	.	p	.	0	N473E	NONSYN	1417	1419	AAT	1704	1706	GAG	163;165;162	G;A;G	151;149;151	.	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	0	.	p	.	0	N513Y	NONSYN	1537	1539	AAC	1824	1826	TAC	144;143;147	T;A;C	136;135;138	.	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	0	.	p	.	0	G517A	NONSYN	1549	1551	GGT	1836	1838	GCC	159;159;159	G;C;C	147;148;148	.	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	0	.	p	.	0	A550T	NONSYN	1648	1650	GCA	1935	1937	ACA	144;147;149	A;C;A,G	134;137;137,1	.	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1218	1220	GCA	195;196;198	G;C;A	180;176;182	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1221	1223	ATC	200;200;202	A;T;C	181;181;183	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1233	1235	GTG	202;204;205	G;T;G	187;187;188	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1233	1235	GTG	202;204;205	G;T;G	187;187;188	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1791	1793	GCG	136;134;136	G;C;G	121;109;115	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1791	1793	GCG	136;134;136	G;C;G	121;109;115	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1914	1916	GGT	156;156;155	G;G;T	143;144;140	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1923	1925	GGC	147;146;144	G;G;C	135;134;129	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	3758	penA	1752	1752	95.66	penA.l6.c30.ctg.1	2533	147.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1941	1943	CCG	146;147;150	C;C;G	135;135;137	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5402	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3104	173.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1603	1605	CTG	181;183;179	C;T;G	163;168;163	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1784	porA	1146	1146	99.65	porA.l15.c17.ctg.1	1868	95.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	581	581	C	128	C	114	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2894	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1350	209.1	0	.	p	.	0	R143G	NONSYN	427	429	AGA	591	593	GGA	217;217;214	G;G;A	206;205;201	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2894	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1350	209.1	0	.	p	.	0	.	INDELS	629	630	AA	794	796	TAG	227;227;228	T;A,G;G	209;213,1;210	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2894	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1350	209.1	0	.	p	.	0	.	MULTIPLE	631	633	TAC	798	801	CAAT	226;229;232;238	C;A;A;T,A	213;212;215;220,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2894	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1350	209.1	0	.	p	.	0	N212fs	FSHIFT	634	634	A	803	803	T	238	T	224	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2894	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1350	209.1	1	SNP	p	G120K	0	.	.	358	360	GGT	522	524	GGT	242;238;236	G;G;T,C	220;217;211,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2894	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1350	209.1	1	SNP	p	A121D	0	.	.	361	363	GCC	525	527	GCC	232;231;230	G,A;C;C	206,1;210;211	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2894	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1350	209.1	1	SNP	p	A121N	0	.	.	361	363	GCC	525	527	GCC	232;231;230	G,A;C;C	206,1;210;211	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10884	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	4996	217.2	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2059	2061	CAT	238;238;241	C;A;T	221;224;223	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1158	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1074	107.4	1	SNP	p	V57M	0	.	.	169	171	GTG	578	580	GTG	222;220;219	G;T;G	205;202;201	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
